A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
This study is ongoing, but not recruiting participants.
Information provided by:
First received: August 20, 2002
Last updated: June 23, 2005
Last verified: November 2002
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Study Completion Date:||No date given|
|Primary Completion Date:||No date given|